Close Menu
    Subscribe
    Advertisement

    Events Search and Views Navigation

    Event Views Navigation

    Today

    Developing a Long-Term Strategy for Low-Dose Radiation Research in the U.S.

    Virtual Event Virtual Event

    This meeting hosted by the National Academies will focus on receiving information from the research community on low dose radiation research priorities and lessons to be learned from managing multidisciplinary programs. What are your views on research priorities for low dose radiation research? How can epidemiology contribute to further understanding risks? Molecular approaches to improve

    Enhanced Drug Distribution Security at the Package Level

    Virtual Event Virtual Event

    The FDA will hold a virtual public meeting on November 16, 2021, on enhanced drug distribution security at the package level. The purpose of this public meeting is to provide members of the pharmaceutical distribution supply chain and other interested stakeholders an opportunity to provide input to FDA on the implementation of the enhanced drug

    ASTMH 2021 Annual Meeting

    Virtual Event Virtual Event

    The American Society for Tropical Medicine and Hygiene (ASTMH) will gather virtually from 17-21 November for the Annual Meeting of leaders and scientific experts invested in tropical medicine and global health. The virtual gathering will feature a wide range of COVID-19 related work, including reports on the potential protective effects of malaria, new vaccine innovations

    Recovery and Resilience: Webinar 2

    Virtual Event Virtual Event

    The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care

    Antimicrobial Drugs Advisory Committee (AMDAC) Meeting

    Virtual Event Virtual Event

    The FDA Antimicrobial Drugs Advisory Committee (AMDAC) will convene on 30 November 2021 to discuss Merck and Ridgeback’s request for emergency use (EUA) of molnupiravir oral capsules for treatment of mild to moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. an investigational antiviral drug to treat COVID-19. FDA

    Prevention and Preparedness: Webinar 3

    Virtual Event Virtual Event

    The COVID-19 pandemic has illuminated and exacerbated challenges in caring for people of all ages with serious illness. The response to many of these challenges involved rapid innovation and as such provides valuable lessons learned that will likely significantly alter the field of serious illness care in the post-pandemic era. The Roundtable on Quality Care

    One Health: Integrating Human, Animal and Environmental Health

    Virtual Event Virtual Event

    A virtual science conference on One Health: Integrating Human, Animal and Environmental Health will be held 3 December 2021. The One Health movement, which has come to prominence in the last decade, advocates greater cross-sectoral collaboration and communication across the human-animal-environment interface. There has been a long-standing recognition that population health is intrinsically linked to

    Current Concepts in Quantitative Risk Assessment for Skin Sensitization

    Virtual Event Virtual Event

    The NTP Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) is partnering with the Swiss Centre for Applied Human Toxicology and the Swiss State Secretariat for Economic Affairs to present a webinar series on “Current Concepts in Quantitative Risk Assessment for Skin Sensitization.” The next webinar in the series on December 8 will

    National Biodefense Science Board Meeting

    Virtual Event Virtual Event

    The National Biodefense Science Board (NBSB) will meet in public (virtually) on December 16, 2021, to provide advice and recommendations to ASPR regarding the development of the 2023-2026 National Health Security Strategy and to discuss other matters of current important for public health emergency preparedness, response, and recovery. A more detailed agenda will be available